Skip to main content
. 2019 Oct;31(5):749–758. doi: 10.21147/j.issn.1000-9604.2019.05.05

3.

3

Multivariate Cox analyses for progression-free survival (PFS) in 415 patients before propensity score-matching (PSM). ECOG, Eastern Cooperative Oncology Group; EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; HR, hazard ratio; 95% CI, 95% confidence interval.